Celadon Pharmaceuticals PLC (CEL) — Net Asset Momentum
Celadon Pharmaceuticals PLC (CEL) recorded a net asset momentum of -54.8% as of December 2023, with net assets of GBX3.18 Million GBX. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Celadon Pharmaceuticals PLC (CEL) net assets for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Celadon Pharmaceuticals PLC Net Asset Momentum (2019–2023)
This chart tracks Celadon Pharmaceuticals PLC's year-over-year net asset growth across 5 annual reporting periods from 2019 to 2023. The most recent momentum reading is -54.8%, with net assets of GBX3.18 Million GBX as of December 2023. For live market cap and overall valuation, see CEL market cap overview.
Annual Net Asset History for Celadon Pharmaceuticals PLC (2019–2023)
The table below shows the complete annual net asset history for Celadon Pharmaceuticals PLC from 2019 to 2023, covering 5 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check tangible net worth ratio of Celadon Pharmaceuticals PLC to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (GBX) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2023 | GBX3.18 Million | GBX9.22 Million | GBX6.04 Million | ▼ -54.8% |
| 2022 | GBX7.04 Million | GBX13.25 Million | GBX6.21 Million | ▲ +9.8% |
| 2021 | GBX6.41 Million | GBX6.61 Million | GBX197.23K | ▲ +6373.2% |
| 2020 | GBX99.03K | GBX3.85 Million | GBX3.75 Million | ▲ +187.3% |
| 2019 | GBX-113.47K | GBX2.49 Million | GBX2.60 Million | — |